May 12, 2021
How not to be an enabler: The implications of Amgen v. Sanofi and Regeneron for antibody claims and beyond
Speaker, New Jersey Intellectual Property Law Association (NJIPLA)
Key Contacts
This site uses cookies to enhance functionality and performance. You may change your cookie settings at any time. If you do nothing, you are giving implied consent to the use of cookies on this website.